Bioworld Financial Watch articles from October 2005

Bioworld Financial Watch archives from October 2005

ArQule's checkpoint bid seems poised for success.
October 3, 2005... About a year and a half ago, investors began to take serious note of ArQule Inc. when the company leveraged its Activated Checkpoint Therapy--gained in the $25 million buyout of Cyclis Pharmaceuticals Inc.--into an unquestionably handsome deal...

10 biggest U.S. gainers for the week.
October 3, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Critical Thera 51.94 Memory 48.90 Cell Therapeu 43.72 Siga Technol 30.86 Sequenom 26.32 Genelabs 23.08 MannKind ...

10 biggest U.S. losers for the week.
October 3, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Cypress -58.29 Incyte Genomics -35.17 Alliance -26.67 Exact Sciences -17.27 MacroChem -16.67 Praecis -16.07 Oxis Int'l ...

Biotech mergers and acquisitions: July 1-Sept. 28, 2005.
October 3, 2005... Biotech Mergers And Acquisitions: July 1-Sept. 28, 2005 I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) (Country;...

BioWorld stock report for public biotechnology companies.
October 3, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 9/23 9/30 ...

Analyst: Insmed growth drug 'approvable'--but unlikely.(FDA Mum On What's Next)
October 10, 2005... In the race between Insmed Inc. and Tercica Inc. to grab market share with their growth hormone deficiency drugs, the only thing certain is uncertainty. Late last month, Insmed chalked up an approvable letter from the FDA for its product...

10 biggest U.S. gainers for the week.
October 10, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Deltagen 33.33 Hemispherx 24.71 Novavax 22.86 MacroChem 20.00 Access Pharma 18.18 Siga Technol 16.98 BioCryst 16.87 Cygnus ...

10 biggest U.S. losers for the week.
October 10, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) CancerVax -54.94 Human Genome -35.39 Savient Pharma -19.89 Sequenom -19.79 Cardiovas Biother -18.18 LifeCell -17.94 Ortec Int'l...

Public financing of biotechnology: September 2005.
October 10, 2005... Public Financing Of Biotechnology: September 2005 I. COMMENCED TRADING IN SEPTEMBER Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units (M) Out ...

Other financings of public biotechnology companies: September 2005.
October 10, 2005... Other Financings Of Public Biotechnology Companies: September 2005 TOTAL: $570.9M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: September 2005.
October 10, 2005... Venture Capital And Corporate Investments In Biotechnology Companies: September 2005 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $361.55M Company Location Date Amt. (M) A&G ...

Money raised by biotech in 2005: January-September.
October 10, 2005... Money Raised By Biotech In 2005: January-September Type of Jan. Feb. March April May financing Public offerings 585.7 799.4 303.9 71.2 143.3 Private biotechs 406.3 636.6 ...

These graphs compare the performance of the biotech stocks for 2005 using two different measures.
October 10, 2005... These graphs compare the performance of the biotech stocks for 2005 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 284 U.S. biotech and biotech-related stocks that are...

BioWorld stock report for public biotechnology companies.
October 10, 2005... BioWorld Stock Report For Public Biotechnology Companies Change Company Symbol Close Close Vol 10/3 10/10 WK...

10 biggest U.S. gainers for the week.
October 17, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) BioCryst 46.54 Praecis 44.90 Access Pharma 33.65 AVI BioPharma 25.47 Novavax 19.53 Lifecore Bio ...

10 biggest U.S. losers for the week.
October 17, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Cerus Corp. -22.73 Threshold Pharma -21.51 Biopure -19.64 Third Wave Tech -17.94 Immune Resp -17.78 La Jolla Pharma ...

EST-patent ruling puts more squeeze on 'pure' Genomics.(Stronger Utility Standard Upheld)
October 17, 2005... "War! What is it good for? Absolutely nothin',' boomed an over-the-top hippie anthem from the late 1960s. But in biotechnology, battles over intellectual property--drawn out and costly as they may be--often prove to be the only way to resolve...

Clinical trials update: September 2005.
October 17, 2005... Clinical Trials Update: September 2005 Company * (Country; Symbol) Product Description AUTOIMMUNE Alba AT-1001 Oral zonulin receptor Therapeutics antagonist Corp....

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: September 2005.
October 17, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: September 2005 Company * (Country; Symbol) Product Description AUTOIMMUNE Active Biotech Laquinimod Immunomodulatory AB...

FDA submissions, approvals and other actions: September 2005.
October 17, 2005... FDA Submissions, Approvals And Other Actions: September 2005 Company * (Country; Symbol) Product Description AUTOIMMUNE Aspreva CellCept Mycophenolate mofetil; Pharmaceuticals ...

BioWorld stock report for public biotechnology companies.
October 17, 2005... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 10/7 10/14 Aastrom Biosci ASTM 2.21 2.1 Abgenix ABGX 10.64...

Despite all trouble, investors demand 'definitive advances'.(BIO InvestorForum 2005)
October 24, 2005... SAN FRANCISCO -- The differing priorities of the FDA, the public and would-be litigators in drug development's much-discussed risk-benefit ratio became one of the topics during a panel talk at the Biotechnology Industry Organization's...

10 biggest U.S. gainers for the week.
October 24, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Novavax 45.14 Generex Biotech 34.72 Indevus 21.40 Matritech 20.00 Questcor Pharma 18.75 Seattle Genetics 17.54 CancerVax ...

10 biggest U.S. losers for the week.
October 24, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) MacroChem -40.00 Osteotech -24.74 Access Pharma -21.58 Xcyte Therapies -17.39 Large Scale -16.46 GenVec -14.72 Cytogen -13.94...

Collaborations between biotech and pharmaceutical companies: Aug. 19-Oct. 19, 2005.
October 24, 2005... Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005 Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Affibody AB * Agilent Deal to...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: Aug. 19-Oct. 19, 2005.
October 24, 2005... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005 Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Affibody AB *...

Biotech--Big Pharma collaborations: modified and terminated agreements, Aug. 19-Oct. 19, 2005.
October 24, 2005... Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Aug. 19-Oct. 19, 2005 I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) agreement...

BioWorld stock report for public biotechnology companies.
October 24, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 10/14 10/21 WK...

Analyst: mighty Gilead eying second-line HIV marketplace.(First-Line Sewn Up For 'Decades')
October 31, 2005... Hope for the expanding arsenal of drugs against HIV continued to grow last week with news of Tanox Inc.'s favorable Phase II data from an ongoing trial with TNX-355, the entry inhibitor that's in line to become the first monoclonal antibody...

10 biggest U.S. gainers for the week.
October 31, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) MacroChem 66.67 CombiMatrix 34.33 Hemispherx 33.18 Regeneron 33.00 Matritech 28.79 Indevus 21.58 Generex Biotech ...

10 biggest U.S. losers for the week.
October 31, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Orchid -34.52 Pharsight -31.03 Critical Thera -22.88 Oxis Int'l -22.22 Large Scale -21.21 CancerVax -18.18 Alteon ...

Biotechnology company deals with other biotechnology companies: collaborations and other agreements, Aug. 24-Oct. 26, 2005.
October 31, 2005... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations And Other Agreements, Aug. 24-Oct. 26, 2005 Company * Company * Type/Product Area (Country; (Country; Symbol) ...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, Aug. 24- Oct. 26, 2005.
October 31, 2005... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Aug. 24- Oct. 26, 2005 Company * Company Type/Product Area (Country; Symbol) Neurobiological Celtic...

Manufacturing, marketing and distribution agreements between biotech companies: Aug. 24-Oct. 26, 2005.
October 31, 2005... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Aug. 24-Oct. 26, 2005 Company * Company * Product (Country; (Country; Symbol) Symbol) Amarillo ...

Biotech--biotech collaborations: modified and terminated agreements, Aug. 24-Oct. 26, 2005.
October 31, 2005... Biotech -- Biotech Collaborations: Modified And Terminated Agreements, Aug. 24-Oct. 26, 2005 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement Symbol) Symbol)...

BioWorld stock report for public biotechnology.(Companies)
October 31, 2005... BioWorld Stock Report For Public Biotechnology % Change Company Symbol Close Close Vol 10/21 10/28 WK ...